At CRU Global, we combine world-class clinical operations with strategic investment expertise to de-risk and accelerate the journey of biotech and medtech innovators.

Full-Service Clinical Operations – From preclinical to Phase II/III, our global network of owned and partner research clinics ensures seamless execution across therapeutic areas. Our 350+ successful clinical trials speak to our operational excellence and commitment to advancing science.

Strategic Co-Investment – Through CRU Ventures and PMK Ventures, we invest alongside leading syndicates and venture partners, providing both equity and in-kind support. This unique model minimizes financial risk, stabilizes funding, and strengthens investor confidence.

Risk Mitigation Expertise – With rigorous upfront planning, real-time data monitoring, and dedicated global oversight teams, we consistently reduce trial disruptions and deliver faster, more reliable outcomes.

Global Portfolio & Partnerships – Our investments span breakthrough therapies in CNS diseases, metabolic disorders, oncology, and infectious diseases, with portfolio companies advancing toward IPOs, licensing deals, and commercialization milestones.

By balancing clinical expertise with capital investment, CRU Global delivers lower failure rates, accelerated timelines, and clear ROI for innovators and investors alike.

With operations across Europe, North America, and Asia, we partner with startups, spin-offs, and established players to unlock growth at every stage of development.

CRU Global Network

Org chart

Teams

Offices